Table 2

The distribution of the number of attacks in the six individual HIDS patients during the crossover trial among placebo and thalidomide (200 mg/day)

No. in HIDS RegistryPlaceboWashoutThalidomide
  4100
 26332
 27321
31103
 89413
102111
   Total13710